UGP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.645000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.395000E-01
Normal-vs-Stage2
9.598400E-01
Normal-vs-Stage3
5.378800E-01
Normal-vs-Stage4
2.950000E-01
Stage1-vs-Stage2
5.889600E-01
Stage1-vs-Stage3
6.969000E-01
Stage1-vs-Stage4
1.771220E-01
Stage2-vs-Stage3
3.008200E-01
Stage2-vs-Stage4
1.699220E-01
Stage3-vs-Stage4
1.316770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.422200E-01
Normal-vs-AfricanAmerican
8.708200E-01
Normal-vs-Asian
4.566600E-01
Caucasian-vs-AfricanAmerican
5.845800E-01
Caucasian-vs-Asian
5.020400E-01
AfricanAmerican-vs-Asian
2.676000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.287800E-01
Normal-vs-Female
9.298200E-01
Male-vs-Female
5.701800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.911000E-01
Normal-vs-Age(41-60Yrs)
7.197200E-01
Normal-vs-Age(61-80Yrs)
6.955400E-01
Normal-vs-Age(81-100Yrs)
8.524400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.192450E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.468600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.879400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.061500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.166800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.371200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.810200E-01
Normal-vs-Daily Drinker
4.665000E-01
Normal-vs-Weekly Drinker
3.423000E-01
Normal-vs-Occasional Drinker
8.874200E-01
Normal-vs-Social Drinker
9.189400E-01
Non Drinker-vs-Daily Drinker
5.773400E-01
Non Drinker-vs-Weekly Drinker
4.414200E-01
Non Drinker-vs-Occasional Drinker
2.603600E-01
Non Drinker-vs-Social Drinker
5.703400E-01
Daily Drinker-vs-Weekly Drinker
7.692000E-01
Daily Drinker-vs-Occasional Drinker
9.516000E-02
Daily Drinker-vs-Social Drinker
2.966200E-01
Weekly Drinker-vs-Occasional Drinker
6.630500E-02
Weekly Drinker-vs-Social Drinker
2.263000E-01
Occasional Drinker-vs-Social Drinker
6.686400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.234400E-01
Normal-vs-Grade 2
6.702800E-03
Normal-vs-Grade 3
1.776210E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.063650E-02
Grade 1-vs-Grade 3
1.452350E-02
Grade 1-vs-Grade 4
2.234400E-01
Grade 2-vs-Grade 3
9.184200E-01
Grade 2-vs-Grade 4
6.702800E-03
Grade 3-vs-Grade 4
1.776210E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.116200E-01
Normal-vs-NonDiabetic
6.954600E-01
Diabetic-vs-NonDiabetic
7.061200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.595600E-01
Normal-vs-NoPancreatitis
7.754400E-01
Pancreatitis-vs-NoPancreatitis
9.039200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.968400E-01
Normal-vs-N1
9.701600E-01
N0-vs-N1
5.397700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.597800E-01
Normal-vs-TP53-NonMutant
5.408000E-01
TP53-Mutant-vs-TP53-NonMutant
9.288400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
